Latest Psoriasis Stories
Lexington Int’l is pleased to announce the publication of the results of a clinical review with the HairMax LaserComb in a peer-review medical journal, validating efficacy for treating hereditary
TNF-Alpha Inhibitors--Including Sales Leader Humira--Accounted for Over 90 Percent of the Psoriatic Arthritis Market, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc.
Sodrec Medical Solutions, Inc. to Partner for US Sales TUSTIN, Calif., Sept. 2, 2014 /PRNewswire/ -- BioPhotas, Inc.
PETACH TIKVA, Israel, Sept. 2, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
Psoriasis is the most common autoimmune disease in the U.S.
The Editorial Board of Living with a Disability magazine has published an important new article on skin disorders as a disabling condition in order to mark National Psoriasis Awareness Month,
Blaine Labs, Inc.
Be Joint Smart to educate roughly 43,500 local residents with PsA about their disease PORTLAND, Ore., Aug. 20, 2014 /PRNewswire-USNewswire/ -- If you're one of the roughly 43,500 D.C.
- A serpent whose bite was fabled to produce intense thirst.